Table 1 Clinical Parameters of recruited patients

From: The Role of Receptor for Advanced Glycation End Products in Airway Inflammation in CF and CF related Diabetes

Characteristic

Healthy

CF

CFRD

Diabetic

P

Gender (M/F)

4/6 (n = 10)

4/1 (n = 5)

2/3 (n = 5)

5/2 (n = 7)

-

Age (Years)

38.9 ± 9.47

31.4 ± 9.71

33.6 ± 10.88

25.29 ± 7.76

0.1079

FEV1/FVC % predicted

81.60 ± 8.51

62.59 ± 17.99*

60.39 ± 9.47*

92.14 ± 13.03

0.0002*

BMI (kgm−2)

25.5 ± 4.06

21.61 ± 3.58

30.72 ± 21.13

27.46 ± 6.01

0.5182

HbA1c (%)

-

5.9 ± 0.22

6.98 ± 0.75*

7.57 ± 0.93*

0.0282*0.0072*

CRP

-

12.97 ± 4.63

4.57 ± 3.32

-

0.063

WCC

-

9.57 ± 1.86

10.9 ± 2.96

-

0.5277

  1. The clinical parameters are shown as mean ± standard deviation, *statistically significant; M, Male; F, Female; CF, cystic fibrosis; CFRD, cystic fibrosis related diabetes; FEV1/FVC, forced expiratory volume/forced vital capacity; BMI, body mass index; HbA1c, haemoglobin A1c; CRP, C-reactive protein; WCC, white blood cell count.
Back to article page